Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Read more about Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025. Read more about NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025.
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025. Read more about NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.
Adult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Read more about Adult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Read more about Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Read more about Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025. Read more about NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.
Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Read more about Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study. Read more about YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study.
CRE25-035: Vascular Endothelial Growth Factor Inhibitor-Induced Radiation Recall Tracheitis in a CASTLE Carcinoma of the Thyroid Patient. Read more about CRE25-035: Vascular Endothelial Growth Factor Inhibitor-Induced Radiation Recall Tracheitis in a CASTLE Carcinoma of the Thyroid Patient.
